Initiative focuses on early diagnosis, gut health awareness and long-term gluten-free care for children with celiac disease
The global pharmaceutical company has been featured in both the DJBIC World Index and the DJBIC Emerging Markets Index
Tecentriq SC reduces treatment administration time by nearly 80 percent and has the potential to lower indirect treatment costs
Baxfendy works in a fundamentally different way from current therapies
New Delhi facility expands Lupin’s specialized neuro-rehabilitation network after Mumbai and Hyderabad launches
Nationwide preventive health initiative aims to make cardiovascular screening at age 30 a standard healthcare milestone
Africa CDC activates continental coordination measures; consultations underway on possible Public Health Emergency declaration
The 38% adjusted EBITDA margin of base business has been supported by robust growth in the CDMO segment
The Ibuprofen business posted a negative EBITDA of Rs. 179 million in Q4 despite revenue rising 61% year-on-year to Rs. 849 million
Subscribe To Our Newsletter & Stay Updated
